483 Cedarburg Pharmaceuticals Apr 2003

483 Cedarburg Pharmaceuticals Apr 2003

Charles Cote FDA$119.00 - Available Now

FDA investigators audited the Cedarburg Pharmaceuticals - Grafton, WI, United States facility and issued inspectional observations (via FDA 483) on 11 Apr 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Apr 2003
  • Location: Grafton, United States
  • FEI: 3001655239
Add To Cart